Drug Topics
APRIL 28, 2025
Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses litigious, market-based, and legislative reform for pharmacy benefit managers.
STAT
APRIL 28, 2025
For the second consecutive year, the pharmaceutical industry saw its reputation slip among patient advocacy groups, largely due to ongoing concerns over pricing issues, according to a new survey. Of more than 2,500 groups queried, 56% reported the industry had an “excellent” or “good” reputation as it goes about the business of developing and providing medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 28, 2025
A conversation with Katherine Tromp, PharmD, interim dean at Northeast Ohio Medical University College of Pharmacy.
PhRMA
APRIL 28, 2025
As the United States confronts a resurgence of measles – a disease that was declared eliminated from the United States in 2000 through immunization – it’s a timely reminder of why vaccines remain one of the most powerful tools for preventing dangerous disease, protecting public health and reducing burden on the health care system.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 28, 2025
Researchers identified differences in naloxone training, policies, procedures, and preferences among chain or independent pharmacies across Alabama.
Pharma Marketing Network
APRIL 28, 2025
Introduction Imagine standing at the edge of a revolution, where every tool you need to succeed is finally within reach. That’s precisely where pharmaceutical marketers find themselves today. Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
APRIL 28, 2025
After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.
Pharmaceutical Technology
APRIL 28, 2025
Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.
PharmaVoice
APRIL 28, 2025
BMS hopes to broaden the applications for the new schizophrenia drug into areas such as Alzheimer’s disease.
Fierce Healthcare
APRIL 28, 2025
Downtime across 39 hospitals over the past several days was reportedly caused by Oracle Health engineers' mistaken database deletion. The hospitals shifted to paper records and "were able to maintain services with no material impact," CHS said.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 28, 2025
The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr
Pharmacy Times
APRIL 28, 2025
Integrating community pharmacists into specialty pharmacy care can enhance patient access, address physician shortages, and expand pharmacists' roles in delivering high-quality clinical services, according to experts at Asembias AXS25 Summit.
pharmaphorum
APRIL 28, 2025
Does the Novavax delay augur a COVID vaccine policy change? Jonah.
Pharmacy Times
APRIL 28, 2025
AI may help to accurately classify pediatric sarcoma subtypes using digitized pathology images, potentially improving diagnosis and treatment accessibility across diverse health care settings.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
APRIL 28, 2025
Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD)
Pharmacy Times
APRIL 28, 2025
Ochsner Childrens Hospital, in partnership with ISMP, has launched a fellowship to advance pediatric medication safety through hands-on training in key competencies, national safety strategies, interdisciplinary collaboration, and innovative tools such as AI and data dashboards.
Pharmaceutical Technology
APRIL 28, 2025
The FDA has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's disease.
Pharmacy Times
APRIL 28, 2025
Experts at Asembias AXS25 Summit discussed the economics of specialty pharmacy for rare diseases, addressing high treatment costs and strategies for balancing innovation.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
APRIL 28, 2025
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion.
Pharmacy Times
APRIL 28, 2025
No matter what role you are in as a pharmacist, no matter where you work or how long you have been practicing, understand that making a difference in the life of a patient matters.
Pharmaceutical Commerce
APRIL 28, 2025
A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.
Pharmacy Times
APRIL 28, 2025
Dostarlimab in the neoadjuvant setting yielded a 100% clinical complete response in patients with rectal cancer.
Pharmaceutical Commerce
APRIL 28, 2025
Tiara Green, president, Accessia Health, highlights key themes from the upcoming discussion on how health equity, literacy, and social determinants are reshaping patient careespecially for those with chronic and rare conditions.
Pharmacy Times
APRIL 28, 2025
Certain antibiotics may have a more significant impact on CAR T-cell efficacy and toxicity.
PharmExec
APRIL 28, 2025
Tiara Green, president, Accessia Health, highlights key themes from the upcoming discussion on how health equity, literacy, and social determinants are reshaping patient careespecially for those with chronic and rare conditions.
Pharmacy Times
APRIL 28, 2025
Patients Should Also Have a Diet Rich in Fruits, Oily Fish, and Cereals
PharmExec
APRIL 28, 2025
A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.
Pharmacy Times
APRIL 28, 2025
Panelists discuss how the initiation of statin therapy requires careful consideration of contraindications and patient-specific factors, particularly in those with liver disease, renal impairment, or advanced age, while noting evolving treatment patterns toward more intensive low-density lipoprotein cholesterol (LDL-C)lowering therapies based on individualized risk assessment.
Pharmaceutical Commerce
APRIL 28, 2025
Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.
PharmExec
APRIL 28, 2025
Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.
Pharmaceutical Technology
APRIL 28, 2025
The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC).
Pharmaceutical Commerce
APRIL 28, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of Theratechnologies, describes the uneasiness behind regulatory complications.
Pharmaceutical Technology
APRIL 28, 2025
Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks Therapeutics.
Expert insights. Personalized for you.
640 
Let's personalize your content